Skip to content

Insider · CIK 0001700533

Steven Denbaars

director

Files at SMTK (SmartKem, Inc.), ALMU (Aeluma, Inc.), PALX (Palomino Laboratories Inc.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 29, 2025PALX
Palomino Laboratories Inc.
JOther
Common Stock
+1,625,000--1,750,000Oct 9, 2025
Sep 29, 2025PALX
Palomino Laboratories Inc.
SOpen-market sale
Warrantsderivative
+125,000$1.20$150k125,000Oct 9, 2025
Sep 3, 2025SMTK
SmartKem, Inc.
AGrant or award
Stock Option (right to buy)derivative
+22,466$0.00$022,466Sep 12, 2025
May 28, 2025SMTK
SmartKem, Inc.
AGrant or award
Stock Option (right to Buy)derivative
+23,915$0.00$023,915May 28, 2025
Jan 10, 2025ALMU
Aeluma, Inc.
AGrant or award
Stock Optionderivative
+84,663$7.80$660k127,942May 23, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Steven Denbaars: insider trades and track record | InsiderTell